-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse NasdaqUSDISIN US09058V1035-
BioCryst PharmaceuticalsBörse Börse BerlinEURSymbol BO1
-
BioCryst PharmaceuticalsBörse Börse MünchenEURSymbol BO1
-
BIOCRYST PHARMACEUTICALS INCBörse Gettex System der Börse MünchenEURSymbol BO1
-
BIOCRYST PHARMACEUTICALS INCBörse Quotrix System der Börse DüsseldorfEURSymbol BO1
-
BIOCRYST PHARMACEUTICALS INCBörse Börse StuttgartEURSymbol BO1
-
BIOCRYST PHARMACEUTICALS INCBörse Börse DüsseldorfEURSymbol BO1
-
BIOCRYST PHARMACEUTICALS INCBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol BO1
-
BioCryst PharmaceuticalsBörse NasdaqISIN US09058V1035 WKN: 896047USDSymbol BCRX
-
ISIN US09058V1035 WKN: 896047USDSymbol BCRX
-
EURSymbol BO1
-
MXN
-
ISIN US09058V1035
WKN 896047
Symbol BCRX
Währung
USD
Börse
Nasdaq Zeitzone: America/Mexico_City
Firmenname
BioCryst Pharmaceuticals, Inc
Marktkapitalisierung
2.218.153.600 (+- 6%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
2.092.307.200 oder 2.344.000.000
Mitarbeiter
336 (+- 58%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
140 oder 531 Mitarbeiter
EBITDA -106.253.000
PEGRatio -0.28
Buchwert 0.191
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 17,07 USD +0,17%
Portrait der BioCryst Pharmaceuticals Aktie
Das Unternehmen BioCryst Pharmaceuticals, Inc aus USA beschäftigt 336 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie tätig.
Das Unternehmen BioCryst Pharmaceuticals, Inc ist nur in 8 ETFs enthalten und somit eine nicht sonderlich bekannte oder beliebte Aktie. Der Spitzenreiter First Trust Small Cap Gr AlphaDEX® ETF gewichtet BioCryst Pharmaceuticals mit 0,54% im ETF.
Entdecke die 6 ETFs in denen BioCryst Pharmaceuticals, Inc am höchsten gewichtet ist Insgesamt in 8 ETFs enthalten
Dir gefallen die Informationen zu BioCryst Pharmaceuticals?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu BioCryst Pharmaceuticals?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu BioCryst Pharmaceuticals?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu BioCryst Pharmaceuticals?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
36 News & Informationen zur BioCryst Pharmaceuticals Aktie
Biocryst Pharmaceuticals Inc (BCRX): Price Now Near $16.17; Daily Chart Shows An Uptrend on 100 Day Basis
It's been a feast for bulls operating on an hourly timeframe, as bcrx has now gone up 4 of the past 5 hours.
BioCryst Appoints Dr. Steven Galson To Board Of Directors
RESEARCH TRIANGLE PARK, N.C., Aug. 26, 2021 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company has appointed
BioCryst Announces Acceptance of Regulatory Applications for ORLADEYO® (berotralstat) by Health Canada and Swissmedic
RESEARCH TRIANGLE PARK, N.C., Aug. 25, 2021 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the new drug…
Pre-market Movers: GTIM, UPST, ZME, WAFU, WW, HYRE…
The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 5.28 A.M. EDT)..
BioCryst Pharma Withdraws Proposed Public Offering
(RTTNews) – BioCryst Pharmaceuticals Inc. (BCRX) said that it has withdrawn its proposed public offering. It believes that current market conditio…
BioCryst Withdraws Public Offering
RESEARCH TRIANGLE PARK, N.C., Aug. 10, 2021 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) announced today that it has withdrawn its…
BioCryst Withdraws Public Offering
RESEARCH TRIANGLE PARK, N.C., Aug. 10, 2021 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) announced today that it has withdrawn its proposed
BioCryst Commences Public Offering of Common Stock and Pre-Funded Warrants
RESEARCH TRIANGLE PARK, N.C., Aug. 09, 2021 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) announced today that it is offering to…
BioCryst Pharmaceuticals, Inc. 2021 Q2 – Results – Earnings Call Presentation (NASDAQ:BCRX)
The following slide deck was published by BioCryst Pharmaceuticals, Inc.
Stocks That Hit 52-Week Highs On Friday
Before 10 a.m. ET on Friday, 175 companies set new 52-week highs.
Key Facts: Nike (NYSE:NKE) was the biggest company by market cap to set a …
Why BioCryst Pharmaceuticals Rose 8% on Thursday
The company's first commercial drug launch keeps exceeding expectations.
BioCryst Pharmaceuticals, Inc. (BCRX) CEO Jon Stonehouse on Q2 2021 Results – Earnings Call Transcript
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q2 2021 Earnings Conference Call August 04, 2021, 08:30 AM ET Company Participants John Bluth – SVP, IR and Corporate Communications Jon…
EDGAR Filing Documents for 0001171843-21-005528
Earnings Scheduled For August 5, 2021
Companies Reporting Before The Bell
• OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of …
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
RESEARCH TRIANGLE PARK, N.C., Aug. 03, 2021 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation …
Were Hedge Funds Right About Boot Barn Holdings Inc (BOOT)?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However…
3 Biotech Stocks That Could Rocket Higher
Over the past year, these small-cap drugmakers have done well by their shareholders, and more big catalysts could be coming.
Small-Cap Stocks List: Which Ones Should You Buy?
Small-cap stocks have outperformed large cap stocks. They tend to have higher average returns for investors. Although, that comes with more risk.
BioCryst To Report Second Quarter 2021 Financial Results On August 5
RESEARCH TRIANGLE PARK, N.C., July 22, 2021 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its
BioCryst Pharmaceuticals – ORLADEYO Revenue Will Drive Share Price (NASDAQ:BCRX)
Sales of HAE drug ORLADEYO in 1Q21 were surprisingly strong at $10.9 million, reflecting the demand for an oral drug for this indication.
Is Cullinan Oncology, Inc. (CGEM) A Good Stock To Buy?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings…
Is BioCryst Pharmaceuticals, Inc. (BCRX) Going to Burn These Hedge Funds?
A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors…
BioCryst Announces Designs For REDEEM-1 And REDEEM-2 Pivotal Trials With BCX9930 As Oral Monotherapy For Patients With PNH
RESEARCH TRIANGLE PARK, N.C., July 15, 2021 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced the designs for REDEEM-1 and
43 Reasons why Atreca Q3 2021 Acquisition is IMMINENT : StockMarket
Hello folks, How about some real DD instead for a change about something revolutionary and happening right under our noses. I hope you enjoy. I …
BioCryst Reports 96-week Data From APeX-2 Showing ORLADEYO®(berotralstat) Reduced HAE Attack Rate By 80 Percent From Baseline
RESEARCH TRIANGLE PARK, N.C., July 10, 2021 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that hereditary angioedema (HAE)
BioCryst Reports 96-week Data from APeX-2 Showing ORLADEYO®(berotralstat) Reduced HAE Attack Rate by 80 Percent from Baseline
—Multiple data presentations at the European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress 2021 highlight durability of effect and…
18 Key Biopharma Catalysts To Keep An Eye On In Q3
Biopharma stocks underperformed in the first half of 2021, and several of these stocks could be in for a rebound in the coming months. Needham an…
ORLADEYO™ (berotralstat) Data to be Presented at European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress
RESEARCH TRIANGLE PARK, N.C., July 01, 2021 — BioCryst Pharmaceuticals, Inc. today announced multiple upcoming data presentations at the European Academy of Allergy and Clinical Immunology… | July 1, 2021
Up 126% in 2021, Could BioCryst Pharmaceuticals Go Even Higher?
There's more than one opportunity for it to do so.
Should I Avoid Black Stone Minerals LP (BSM)?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their…
The 5 Best Biotech Stocks Under $10
Discoer the best biotech stocks under $10 that can make all the difference in your portfolio. Many investors are keeping an eye on the industry.
Why BioCryst Pharmaceuticals Stock Is Popping Today
Investors cheered good news out of Japan for the company's lead product.
BioCryst Announces Approval Of Japanese NHI Price Listing Of ORLADEYO™ (berotralstat) For Prophylactic Treatment Of Hereditary Angioedema
—ORLADEYO is the first and only approved prophylactic therapy for HAE in Japan—
—NHI price listing triggers $15 million milestone payment to BioCryst—
Locking In Nano Dimension Ltd (NNDM) Gains
Often, these include large cap stocks with high share prices, but last month we picked up a couple of small caps, Nano Dimension Ltd.
Attention Biotech Investors: Mark Your Calendar For January PDUFA Dates
Year-end reviews by the Food and Drug Administration produced mostly positive outcomes, with most therapies passing the regulatory hurdle without …
Attention Biotech Investors: Mark Your Calendar For January PDUFA Dates
Year-end reviews by the Food and Drug Administration produced mostly positive outcomes, with most therapies passing the regulatory hurdle without any …